Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Spitzer

Showing results (181-190 of 300) with videos related to

Pageof 30
Sort By:
VASA. Supplementum|January 1, 1989
[Primary and secondary microangiopathy in patients with essential hypertension]H Kiesewetter, F Jung, W Kolepke, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 13, 2015
Refractive errors, visual impairment, and the use of low-vision devices in albinism in MalawiM Schulze Schwering, N Kumar, D Bohrmann, et al.
Retinal Cases & Brief Reports|January 25, 2021
CLOUDING OF INTRAOCULAR SILICONE OIL IN THE ABSENCE OF EMULSIFICATIONYing Zheng, Jan Willem de Vries, Andreas Herrmann, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 28, 2012
Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human originKai Januschowski, Sebastian Mueller, Martin S Spitzer, et al.
Klinische Wochenschrift|October 1, 1986
Comparative investigation of the microcirculation in patients with hypertension and healthy adultsF Jung, S Spitzer, H Kiesewetter, et al.
Investigative Ophthalmology & Visual Science|July 30, 2024
OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement TherapyWei Chieh Huang, Christina M Ohnsman, Yevgeniya Atiskova, et al.
Thrombosis and Haemostasis|January 1, 1994
Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitroR V Shohet, S Spitzer, E L Madison, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 20, 2016
Long-term results after artificial iris implantation in patients with aniridiaAnnekatrin Rickmann, Peter Szurman, Kai Januschowski, et al.
Retina (Philadelphia, Pa.)|July 13, 2011
Preservative-free triamcinolone acetonide injectable suspension versus "traditional" triamcinolone preparations: impact of aggregate size on retinal biocompatibilityMartin S Spitzer, Tomasz Mlynczak, Maximilian Schultheiss, et al.
Acta Ophthalmologica|January 25, 2012
Cataract as 'initial symptom' of Creutzfeld-Jacob diseaseMartin A Leitritz, Beate Leo-Kottler, Marion Batra, et al.
Pageof 30

Showing results (181-190 of 300) with videos related to

Sort By:
Pageof 30
VASA. Supplementum|January 1, 1989
[Primary and secondary microangiopathy in patients with essential hypertension]H Kiesewetter, F Jung, W Kolepke, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 13, 2015
Refractive errors, visual impairment, and the use of low-vision devices in albinism in MalawiM Schulze Schwering, N Kumar, D Bohrmann, et al.
Retinal Cases & Brief Reports|January 25, 2021
CLOUDING OF INTRAOCULAR SILICONE OIL IN THE ABSENCE OF EMULSIFICATIONYing Zheng, Jan Willem de Vries, Andreas Herrmann, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 28, 2012
Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human originKai Januschowski, Sebastian Mueller, Martin S Spitzer, et al.
Klinische Wochenschrift|October 1, 1986
Comparative investigation of the microcirculation in patients with hypertension and healthy adultsF Jung, S Spitzer, H Kiesewetter, et al.
Investigative Ophthalmology & Visual Science|July 30, 2024
OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement TherapyWei Chieh Huang, Christina M Ohnsman, Yevgeniya Atiskova, et al.
Thrombosis and Haemostasis|January 1, 1994
Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitroR V Shohet, S Spitzer, E L Madison, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 20, 2016
Long-term results after artificial iris implantation in patients with aniridiaAnnekatrin Rickmann, Peter Szurman, Kai Januschowski, et al.
Retina (Philadelphia, Pa.)|July 13, 2011
Preservative-free triamcinolone acetonide injectable suspension versus "traditional" triamcinolone preparations: impact of aggregate size on retinal biocompatibilityMartin S Spitzer, Tomasz Mlynczak, Maximilian Schultheiss, et al.
Acta Ophthalmologica|January 25, 2012
Cataract as 'initial symptom' of Creutzfeld-Jacob diseaseMartin A Leitritz, Beate Leo-Kottler, Marion Batra, et al.
Pageof 30